Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
STOCKS
Perrigo, Taro Show Perils of Failure to Branch in Branded Drugs
By William McConnell
May 23, 2017 4:05 PM EDT
PRESS RELEASES
Strongbridge Biopharma Plc Announces Publication Of Secondary Endpoints Data From Phase 3 SONICS Study Of RECORLEV™ (levoketoconazole) For The Treatment Of Endogenous Cushing's Syndrome In The Journal, Pituitary
By GlobeNewswire
Nov 24, 2020 7:30 AM EST
PRESS RELEASES
Strongbridge Biopharma Plc Announces Participation In Two Upcoming Investor Conferences
By GlobeNewswire
Nov 12, 2020 7:30 AM EST
PRESS RELEASES
Strongbridge Biopharma Plc To Host Third Quarter 2020 Financial Results Conference Call On October 29, 2020
By GlobeNewswire
Oct 22, 2020 7:30 AM EDT
PRESS RELEASES
Strongbridge Biopharma Plc Announces Pricing Of Public Offering Of Ordinary Shares
By GlobeNewswire
Sep 16, 2020 11:29 PM EDT
PRESS RELEASES
Strongbridge Biopharma Plc Announces Proposed Public Offering Of Ordinary Shares
By GlobeNewswire
Sep 16, 2020 4:36 PM EDT
PRESS RELEASES
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Strongbridge Biopharma Plc - SBBP
By PR Newswire
Sep 14, 2020 8:32 PM EDT
PRESS RELEASES
Strongbridge Biopharma Plc Provides Corporate Update
By GlobeNewswire
Sep 8, 2020 8:00 AM EDT
PRESS RELEASES
Strongbridge Biopharma Plc To Host Second Quarter 2020 Financial Results Conference Call On August 4, 2020
By GlobeNewswire
Jul 28, 2020 7:30 AM EDT
PRESS RELEASES
Strongbridge Biopharma Plc Announces Appointment Of John H. Johnson To Chief Executive Officer
By GlobeNewswire
Jul 7, 2020 7:30 AM EDT
PRESS RELEASES
Strongbridge Biopharma Plc Announces Last Patient Completes Last Study Visit In The Randomized Withdrawal Phase Of The LOGICS Trial Evaluating RECORLEV® (levoketoconazole) For Endogenous Cushing's Syndrome
By GlobeNewswire
Jul 1, 2020 7:30 AM EDT
PRESS RELEASES
Strongbridge Biopharma Plc To Present At The Jefferies Virtual Healthcare Conference
By GlobeNewswire
Jun 1, 2020 7:30 AM EDT
PRESS RELEASES
Strongbridge Biopharma Plc Announces $30 Million Debt Facility With Avenue Venture Opportunities Fund, L.P.
By GlobeNewswire
May 20, 2020 7:30 AM EDT
PRESS RELEASES
Strongbridge Biopharma Plc To Present At Upcoming 2020 Solebury Trout Virtual Global Healthcare Conference Series
By GlobeNewswire
May 18, 2020 7:30 AM EDT
PRESS RELEASES
Strongbridge Biopharma Plc To Host First Quarter 2020 Financial Results Conference Call On May 6, 2020
By GlobeNewswire
Apr 20, 2020 7:30 AM EDT
PRESS RELEASES
Strongbridge Biopharma Plc To Present At The Cowen And Company 40th Annual Healthcare Conference
By GlobeNewswire
Feb 27, 2020 7:30 AM EST
PRESS RELEASES
Strongbridge Biopharma Plc To Host Fourth Quarter And Full-Year 2019 Financial Results Conference Call On February 25, 2020
By GlobeNewswire
Feb 19, 2020 7:30 AM EST
PRESS RELEASES
Strongbridge Biopharma Plc Announces New Employment Inducement Awards
By GlobeNewswire
Jan 30, 2020 4:30 PM EST
STOCKS
Perrigo, Taro Show Perils of Failure to Branch in Branded Drugs
By William McConnell
May 23, 2017 4:05 PM EDT
VIDEO
Take a Look at These Stocks Poised to Trade Higher
By TheStreet Staff
Feb 16, 2017 3:14 PM EST
STOCKS
These 5 stocks under $10 could explode higher
By Roberto Pedone
Feb 16, 2017 1:34 PM EST
INVESTING
These 5 stocks under $10 could explode higher soon
By Roberto Pedone
Jan 12, 2017 1:18 PM EST
INVESTING
Chiasma plunges after FDA rejects application for growth disorder drug
By The Fly Staff
Apr 18, 2016 10:24 AM EDT
